|
The implant was returned to the manufacturer and evaluated.The evaluation leads one to believe that fusion occurred because there was evidence of bone growth through the implant and there was bony ingrowth on the implant surfaces.It is possible that after 3.5 years, the device became loose due to patient contraindications (e.G.Osteoporosis, infection, smoking, etc.).This adverse event was documented in the qms at the manufacturer after the event.During an internal audit done in 2018, it was discovered that form 3500a had not been successfully submitted to the fda.It appears to be lack of training on the submission process with esg and a capa was open to address this.
|